Sunday May 31, 2020

Dublin financiers plan medtech AIM listing

Raglan Capital has teamed up with Irish healthcare and life-science veterans to launch a new company, Horizon Medical Technologies, and plans to float it on London’s AIM stock exchange by the end of the year.

15th February, 2015

The Dublin-based corporate financiers plan to target acquisitions in the medical technology sector valued at €5 million to €20 million.

Harry Keenan, previously general manager of UK and Ireland at Baxter International, and Joey Mason, a former partner at Delta Partners who has previously worked in finance and business development with Morgan Stanley and Biotrin, are both working on the new project.

Dave Shanahan, former managing director of Pfizer Healthcare Ireland and head of life...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Many of us have achieved a new life balance that might just be the real ‘new normal’

Sharyn McAndrew | 2 weeks ago

Property firms such as QRE are dealing with the coronavirus lockdown by trying to maintain some normality in their day-to-day business

Conor Whelan | 3 weeks ago

Hardline opposition to EU solidarity in funding the cost of Covid-19 is driven by German allergy to ‘imprudent’ spending, and by Dutch politicians fearing the transfer of funds to southern countries would provoke a far-right backlash

Barry J Whyte | 1 month ago